FR2274285A1 - Administration of disodium chromoglycate or its biologues - by use of a primary dose which does not give inhibition of the allergy followed by a second anti-allergic dose - Google Patents

Administration of disodium chromoglycate or its biologues - by use of a primary dose which does not give inhibition of the allergy followed by a second anti-allergic dose

Info

Publication number
FR2274285A1
FR2274285A1 FR7518590A FR7518590A FR2274285A1 FR 2274285 A1 FR2274285 A1 FR 2274285A1 FR 7518590 A FR7518590 A FR 7518590A FR 7518590 A FR7518590 A FR 7518590A FR 2274285 A1 FR2274285 A1 FR 2274285A1
Authority
FR
France
Prior art keywords
dose
biologues
administration
allergic
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7518590A
Other languages
French (fr)
Other versions
FR2274285B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2274285A1 publication Critical patent/FR2274285A1/en
Application granted granted Critical
Publication of FR2274285B1 publication Critical patent/FR2274285B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedure for the administration of disodium chromoglycate (I) (disodium salt of 1,3-bis(2-carboxychromen-5-yloxy)-2-hydroxy-propane) and its biologues for the prophylactic treatment of reaginine or non-reaginine type allergies, by administration of a first dose of (I) or its biologues which does not assure effective inhibition of the allergic symptoms; followed by a second effective anti-allergic dose of (I) or its biologues in such a quantity that this second dose accures a stronger inhibition of the allergic symptoms than the first dose. Used for prophylactic treatment of allergies such as rhinitis, food allergies, asthma etc. The method of dosage gives high yields of inhibition of allergies with a total dose less than that used previously. The patient is less likely to develop resistance to (I) or suffer from side-effects.
FR7518590A 1974-06-14 1975-06-13 Administration of disodium chromoglycate or its biologues - by use of a primary dose which does not give inhibition of the allergy followed by a second anti-allergic dose Granted FR2274285A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47927774A 1974-06-14 1974-06-14

Publications (2)

Publication Number Publication Date
FR2274285A1 true FR2274285A1 (en) 1976-01-09
FR2274285B1 FR2274285B1 (en) 1978-11-10

Family

ID=23903334

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7518590A Granted FR2274285A1 (en) 1974-06-14 1975-06-13 Administration of disodium chromoglycate or its biologues - by use of a primary dose which does not give inhibition of the allergy followed by a second anti-allergic dose

Country Status (3)

Country Link
BE (1) BE830233A (en)
FR (1) FR2274285A1 (en)
ZA (1) ZA753210B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426460A1 (en) * 1976-05-21 1979-12-21 Fisons Ltd ANTIALLERGIC COMPOSITION

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426460A1 (en) * 1976-05-21 1979-12-21 Fisons Ltd ANTIALLERGIC COMPOSITION

Also Published As

Publication number Publication date
BE830233A (en) 1975-12-15
FR2274285B1 (en) 1978-11-10
ZA753210B (en) 1976-04-28

Similar Documents

Publication Publication Date Title
IS3959A (en) Method of preparation of a composition comprising a medicament which is a bronchodilator and anti-inflammatory drug for the treatment and use of respiratory disorders
ATE204178T1 (en) METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
ZA754725B (en) Preparation for the treatment of infectious diseases, method for the manufacture thereof, and its use
MY8000275A (en) New form of flunisolide and the use of flunisolide to treat respiratory diseases
JPS52130922A (en) Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient
FR2274285A1 (en) Administration of disodium chromoglycate or its biologues - by use of a primary dose which does not give inhibition of the allergy followed by a second anti-allergic dose
DE3380923D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS.
JPS5585526A (en) Remedy for allergic disease
FR2208655A1 (en) Anti allergic disodiumcromoglycate administration - using dosage scheme which gives sensitisation dose followed by lesser supporting dose
BE803319A (en) Anti allergic disodiumcromoglycate administration - using dosage scheme which gives sensitisation dose followed by lesser supporting dose
JPS5246505A (en) Tubing pump
Bywaters Aspects of Steroid Therapy: The Present Status of Steroid Treatment in Rheumatoid Arthritis
SU127202A1 (en) Method of treating human llimatosis
Asbjorn et al. Low dose of gestagen as a contraceptive method. A clinical trial
DALHAMN The influence of some expectorants on the rate of ciliary beat in the trachea of living rats
USD144855S (en) Design for a cigarette case
IT1237341B (en) Intravenous immunoglobulin administration
US2363541A (en) Detoxicant
JPS51139616A (en) A plaster for treating diseases caused by fungi
JPS533534A (en) Local anesthetics
Chang Clinical Aspects of Hyperbaric Oxygen and Radiotherapy
GR11480B (en) PHARMACEUTICAL FOR PREPARATION FOR THE TREATMENT AND PREVENTION OF CHICKEN CHOLERA.
Bickers The treatment of postlumbar puncture headache with DHE-45 (dihydroergotamine): Caldwell, William G.: West. J. Surg. 58: 11, 1950
DAVIS XLVI.—A NEW APPLICATION FOR VARICOSE ULCERS
Rantanek IV Material

Legal Events

Date Code Title Description
ST Notification of lapse